Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC

BACKGROUND: KRAS and BRAF mutations are prognostic and predictive tools in metastatic colorectal cancer, but little is known about their prognostic value in patients scheduled for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Therefore, we analyzed the prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Graf, Wilhelm, Cashin, Peter H., Ghanipour, Lana, Enblad, Malin, Botling, Johan, Terman, Alexei, Birgisson, Helgi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925063/
https://www.ncbi.nlm.nih.gov/pubmed/31571052
http://dx.doi.org/10.1245/s10434-019-07452-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925063/
https://www.ncbi.nlm.nih.gov/pubmed/31571052
http://dx.doi.org/10.1245/s10434-019-07452-2

Ejemplares similares